Back
Zealand Pharma AS Vs. Novo Nordisk AS Industry Stock Comparison
Buy
67
ZLDPF
Zealand Pharma AS
Last Price:
135.65
Seasonality Move:
9.95%
Sell
39
NVO
Novo Nordisk AS
Last Price:
127.73
Seasonality Move:
4.32%
Buy
67
Zealand Pharma AS (ZLDPF)
is a Buy
Is Zealand Pharma AS a Buy, Sell or Hold?
- The current Zealand Pharma AS [ZLDPF] share price is $135.65. The Score for ZLDPF is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- ZLDPF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $127.51. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZLDPF Stock Price Chart
What is Zealand Pharma AS's stock price today?
-
The Zealand Pharma AS share price today is $135.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZLDPF is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $127.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
ZLDPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.56 | Buy |
Relative Strength Index (14 RSI): | 58.77 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (126.16 - 135.04) | Buy |
Bollinger Bands (100): | (97.19 - 135.23) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.53 | Sell |
Relative Strength Index (14 RSI): | 40.25 | Sell |
Chaikin Money Flow: | -1696867 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (131.84 - 137.22) | Sell |
Bollinger Bands (100): | (129.39 - 140.77) | Sell |
ZLDPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 133.93 | Buy |
20-day SMA: | 129.53 | Buy |
50-day SMA: | 130.23 | Buy |
200-day SMA: | 96.32 | Buy |
8-day EMA: | 133.23 | Buy |
20-day EMA: | 131.29 | Buy |
50-day EMA: | 127.48 | Buy |
200-day EMA: | 100.02 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 134.03 | Sell |
20-day SMA: | 134.27 | Sell |
50-day SMA: | 133.19 | Sell |
200-day SMA: | 126.01 | Buy |
8-day EMA: | 132.67 | Sell |
20-day EMA: | 133.56 | Sell |
50-day EMA: | 134.01 | Sell |
200-day EMA: | 124.88 | Buy |
Zealand Pharma AS Earnings Growth & ZLDPF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.91 per share.
Zealand Pharma AS Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |